Recent studies have centered on the convergence of GLP-1|glucose-dependent insulinotropic polypeptide|glucagon receptor agonist therapies and dopamine communication. While GIP agonists are commonly employed for https://safaqjsm079298.articlesblogger.com/64126233/emerging-glp-stimulators-and-dopaminergic-adjustment-a-comparative-overview